clearside
biomedical
report
third
quarter
financial
results
provide
corporate
update
tuesday
november
alpharetta
globe
newswire
clearside
biomedical
nasdaq
clsd
biopharmaceutical
company
dedicated
developing
delivering
treatments
restore
preserve
vision
people
serious
back
eye
diseases
announced
today
third
quarter
financial
results
reported
tuesday
november
close
financial
markets
management
host
webcast
conference
call
eastern
time
discuss
results
provide
corporate
update
live
archived
webcast
may
accessed
clearside
website
investors
section
events
presentations
live
call
accessed
dialing
domestic
international
entering
conference
code
clearside
biomedical
clearside
biomedical
biopharmaceutical
company
dedicated
developing
delivering
treatments
restore
preserve
vision
people
serious
back
eye
diseases
clearside
proprietary
scs
targets
suprachoroidal
space
offers
unique
access
macula
retina
choroid
disease
often
occurs
company
scs
injection
platform
inherently
flexible
procedure
intended
provide
targeted
delivery
site
disease
work
established
new
formulations
medications
well
future
therapeutic
innovations
gene
therapy
information
please
visit
investor
media
contacts
jenny
kobin
remy
bernarda
ir
source
clearside
biomedical
inc
